Composition of Certain Financial Statement Captions (Tables)

6 Months Ended

Jun. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Composition of Certain Financial Statement Captions

(In thousands)	June 30, 2022		December 31, 2021
Accounts receivable, net:
Accounts receivable	$	165,226	$	261,476
Less: allowance for credit losses	(6,801)		(1,839)
	$	158,425	$	259,637
Inventories, net:
Consumable supplies	$	37,054	$	39,447
Finished products	42,321		44,107
Work in-process	1,892		1,615
Raw materials	7,256		6,112
Less: inventory reserve	(5,217)		(4,779)
	$	83,306	$	86,502
Other current assets and prepaid expenses:
Taxes recoverable	$	5,442	$	5,598
Prepaid expenses	12,324		10,641
Prepaid insurance	7,166		4,383
Other receivables	11,273		353
Other	6,358		6,195
	$	42,563	$	27,170
Intangible assets, net:
Customer relationships	$	311,864	$	314,823
Technologies	822,323		246,101
Trade names	49,735		49,770
Covenants not to compete	12,907		12,920
Licenses	5,873		5,766
Product registrations	6,440		6,995
Other	5,755		6,128
Less: accumulated amortization	(352,488)		(320,820)
	$	862,409	$	321,683
Accrued expenses:
Inventory received but not invoiced	$	18,853	$	40,446
Commitments and contingencies	12,745		27,819
Employee benefits	34,368		45,939
Contract liabilities	257		258
Clinical trials	4,245		4,867
Contingent consideration	487		487
Finance leases short-term	2,625		2,257
Professional fees	4,116		2,121
Other	50,558		69,299
	$	128,254	$	193,493

(In thousands)	June 30, 2022		December 31, 2021
Other long-term liabilities:
Contingent consideration	$	2,416	$	2,350
Mortgages and other debts payable	1,680		2,224
Finance leases long-term	4,588		2,924
Contract liabilities	192		208
Other	7,361		7,356
	$	16,237	$	15,062

Changes in Goodwill

The following table summarizes the changes in Goodwill by reporting unit during the six months ended June 30, 2022.

	2022
(In thousands)	Gross goodwill at January 1		Cumulative impairment at January 1		Acquisitions and dispositions		Foreign exchange and other		Balance at June 30
Pharmaceuticals
CURNA	$	4,827	$	(4,827)			$	—	$	—
Rayaldee	86,554		—				(6,652)		79,902
FineTech	11,698		(11,698)				—		—
ModeX	—		—		65,786		—		65,786
OPKO Biologics	139,784		—				—		139,784
OPKO Chile	3,760		—				(301)		3,459
OPKO Health Europe	7,478		—				(589)		6,889
OPKO Mexico	100		(100)				—		—
Transition Therapeutics	3,421		(3,421)				—		—
Diagnostics
BioReference	434,809		—		(151,784)		—		283,025
OPKO Diagnostics	17,977		(17,977)				—		—
	$	710,408	$	(38,023)	$	(85,998)	$	(7,542)	$	578,845